The global smart healthcare market is expected to expand to USD 410.7 Billion by 2031 at a CAGR of 13.4%. The rising geriatric population coupled with the growing desire for patient-centered and individualized treatment is one of the major factors driving the global smart healthcare market. Additionally, with the advent of AI, IoT, and big data analytics, the global smart healthcare market's opportunities have propelled and are anticipated to surge heavily in the upcoming years.
The rising incidence of chronic illnesses like diabetes, heart disease, and respiratory conditions calls for ongoing observation and efficient care, all of which are made possible by intelligent healthcare solutions. Technological developments such as AI, IoT, and big data analytics have greatly expanded the capabilities and uses of smart healthcare systems and devices. Additionally, the adoption of smart healthcare solutions is being driven by the growing desire for patient-centred care and individualised treatment. The aging population, which necessitates ongoing health care, is another factor driving market expansion.
A number of regulatory agencies are essential to the smart healthcare industry as they guarantee the security and effectiveness of systems and equipment. The Food and Drug Administration (FDA) in the U.S. regulates medical equipment, including smart healthcare items. Similar responsibilities are overseen in the European Union by the European Medicines Agency (EMA). The International Organization for Standardization (ISO), which establishes international standards for medical devices, and national health agencies in different nations that implement regional laws are two other significant regulatory organizations.
The market for smart healthcare has various obstacles despite its potential. For certain patients and healthcare providers, the high initial and ongoing expenditures of smart healthcare equipment may be unaffordable. Moreover, data security and privacy are significant issues as smart healthcare systems frequently handle sensitive patient data. Furthermore, the absence of uniform laws and problems with interoperability across various smart healthcare systems may impede market expansion. Another major restraint is the reluctance of healthcare workers to accept new technology because of their unfamiliarity and potential impact on workflow.
The market for smart healthcare presents a wealth of options. The creation of more accurate and effective diagnostic and therapeutic instruments may result from the use of cutting-edge technology like artificial intelligence and machine learning in the healthcare industry. The market is anticipated to expand in the upcoming years owing to the growing use of telemedicine and remote patient monitoring, particularly in the wake of the COVID-19 pandemic. Furthermore, the promotion of digital health and intelligent healthcare solutions through government financing and efforts fosters favorable conditions for industry expansion. For astute healthcare providers, emerging markets with developing healthcare infrastructure also offer unexplored prospects.
Impact of COVID-19
The industry for smart healthcare has been greatly impacted by the COVID-19 pandemic, which has accelerated its growth and implementation. The traditional in-person medical visits became difficult due to social distancing measures and lockdowns, which increased the demand for remote healthcare solutions. As a result, telemedicine and remote patient monitoring services grew quickly, allowing patients to get care while lowering their chance of contracting a virus. Moreover, the pandemic brought to light the significance of real-time monitoring and data analytics—two essential elements of smart healthcare. AI and big data are being used by hospitals and other healthcare providers to optimise resource allocation, forecast outbreaks, and manage patient loads. This change sparked investments and advancements in the healthcare industry while also demonstrating the promise of smart technology. But the pandemic also revealed weaknesses, like the dangers to cybersecurity posed by the growing use of digital health platforms. Furthermore, regulatory agencies were under pressure to accelerate licenses due to the rapid demand for these technologies, which occasionally raised questions about the completeness of evaluations. Despite these difficulties, COVID-19 has generally had a positive effect on the healthcare industry, propelling smart healthcare solutions to the forefront of the worldwide scene.
Segmentation
The market for smart healthcare is segmented into technology, application, and end-user. By technology, the market is segmented into telemedicine, mHealth (Mobile Health), electronic health records (EHR), smart wearables, and AI & Big Data Analytics. By application, the market is further bifurcated into remote patient monitoring, diagnostics & screening, treatment & medical management, and health & wellness. By end users, hospitals & clinics, home care settings, research & academic institutes, and individuals.
Regional Analysis
Based on healthcare infrastructure, regulatory policies, market demand, and technological adoption, there are geographical differences in the smart healthcare market. Due to the highly developed healthcare system and widespread use of digital health technology, North America accounts for a sizable portion of the industry. The key players propelling market expansion in this region are companies like Apple, with its wearable devices, and Apple Health, IBM Watson Health, which specializes in AI-driven healthcare analytics, and Medtronic, with its remote monitoring systems.
The European market is driven by factors such as an aging population, strong healthcare systems, and government support for digital health projects. The prominent companies in this region include Siemens Healthineers, which offers diagnostic imaging and AI-driven healthcare analytics, Philips Healthcare, which is a major player in telehealth and remote patient monitoring systems, and Roche, which is involved in smart diagnostics and personalized healthcare.
The growing awareness of digital health and increased investments in healthcare infrastructure are driving the Asia Pacific region's rapid growth. The notable contributors include Alibaba Health Information Technology, which provides online health services in China; Fujitsu, which offers healthcare IT solutions; and Samsung Healthcare, which offers a range of smart healthcare products.
Despite financial limitations, the Latin American healthcare business is progressively implementing smart technologies to increase efficiency and accessibility. Allscripts Healthcare Solutions offers electronic health records and other health IT solutions, while General Electric (GE) Healthcare offers medical imaging and patient monitoring services in the region.
Government initiatives and investments in healthcare infrastructure are driving growth across the Middle East and Africa. TeleMedC specializes in telemedicine and remote diagnostic solutions in underdeveloped areas; Siemens Healthineers delivers cutting-edge healthcare technologies; and Cerner Corporation offers health information technology solutions.
Competitive Analysis
The key players in the global smart healthcare market are AirStrip Technologies Inc., Allscripts Healthcare Solutions, Apple Inc., AT&T Inc., Brooks Automation, Cerner Corporation, Cisco, GE Healthcare, Given Imaging, Inc., Hurst Green Plastics Ltd., IBM, Logi-Tag, McKesson Corporation, Olympus Corporation, Pepperl+Fuchs, Samsung Electronics Corporation, Siemens Medical Solutions, Solstice Medical LLC, and Stanley IInnerspa, among others.
In December 2023, GE HealthCare and AirStrip jointly announced a marketing agreement. In the U.S., AirStrip's patient monitoring and cardiology solutions will only be distributed by GE HealthCare. Through this collaboration, real-time mobile and online access to patient data is made possible by combining the data visualization capabilities of AirStrip with the patient monitoring technologies of GE HealthCare. To alleviate professional shortages and exhaustion, the partnership seeks to enhance clinical workflow, productivity, and patient care. More than 600 US healthcare institutions can use the solutions.
Similarly, in 2023, Brooks Automation acquired Aim Lab Automation Technologies, which offers engineering, design, and consulting services to companies that make medical devices. Aim Lab Automation Technologies is a Brisbane-based company founded in 1975. Precise Automation was previously purchased by Brooks Automation in 2021.
For the Table of Contents (TOC) of the entire report, Contact Us. We will provide you with the full TOC for the same.
The global smart healthcare market is segmented as follows:
By Technology (Revenue: USD Billion, 2019 – 2031)
● Telemedicine
● mHealth (Mobile Health)
● Electronic Health Records (EHR)
● Smart Wearables
● AI & Big Data Analytics
By Application (Revenue: USD Billion, 2019 – 2031)
● Remote Patient Monitoring
● Diagnostics & Screening
● Treatment & Medication Management
● Health & Wellness
By End User (Revenue: USD Billion, 2019 – 2031)
● Hospitals & Clinics
● Homecare Settings
● Research & Academic Institutes
● Individuals
By Region (Revenue: USD Billion, 2019 – 2031)
● North America
o U.S.
o Canada
o Mexico
● Europe
o U.K.
o France
o Germany
o Italy
o Spain
o Rest of Europe
● Asia Pacific
o China
o Japan
o India
o South Korea
o South East Asia
o Rest of Asia Pacific
● Latin America
o Brazil
o Argentina
o Rest of Latin America
● Middle East & Africa
o GCC Countries
o South Africa
o Rest of Middle East & Africa
Frequently Asked Questions (FAQs)
The global market for the smart healthcare industry is expected to reach USD 410.7 Billion in 2031 growing at a CAGR of 13.4%.
The major players in the global smart healthcare market are AirStrip Technologies Inc., Allscripts Healthcare Solutions, Apple Inc., AT&T Inc., Brooks Automation, Cerner Corporation, Cisco, GE Healthcare, Given Imaging, Inc., Hurst Green Plastics Ltd., IBM, Logi-Tag, McKesson Corporation, Olympus Corporation, Pepperl+Fuchs, Samsung Electronics Corporation, Siemens Medical Solutions, Solstice Medical LLC, and Stanley IInnerspa, among others.
The global smart healthcare market is projected to grow at a CAGR of 13.4% between 2024 and 2031.
The market for global smart healthcare is driven by several factors such as the ageing population globally along with the rising incidences of chronic illnesses. The technological advancements such as AI, IoT, and Big Data Analytics merged with the smart healthcare devices and systems is anticipated to surge the global smart healthcare market in the upcoming years.
North America was the leading regional segment of the global smart healthcare market in 2023.